PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration
Brin, Elena, Wu, Katherine, Lu, Hsin-Tze, He, Yudou, Dai, Zhaoming, He, Wei
Published in Oncotarget (29.08.2017)
Published in Oncotarget (29.08.2017)
Get full text
Journal Article
Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
McAlpine, Jennifer A, Lu, Hsin-Tze, Wu, Katherine C, Knowles, Susan K, Thomson, James A
Published in BMC cancer (28.08.2014)
Published in BMC cancer (28.08.2014)
Get full text
Journal Article